Tumor cell differentiation in embryonal rhabdomyosarcoma (eRMS) impacts clinical presentation and treatment response. Well-differentiated eRMS shows better chemotherapy outcomes, suggesting differentiation is key for prognosis.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: